These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 15048657

  • 1. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome.
    Gothelf D, Presburger G, Zohar AH, Burg M, Nahmani A, Frydman M, Shohat M, Inbar D, Aviram-Goldring A, Yeshaya J, Steinberg T, Finkelstein Y, Frisch A, Weizman A, Apter A.
    Am J Med Genet B Neuropsychiatr Genet; 2004 Apr 01; 126B(1):99-105. PubMed ID: 15048657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome.
    Gothelf D, Presburger G, Levy D, Nahmani A, Burg M, Berant M, Blieden LC, Finkelstein Y, Frisch A, Apter A, Weizman A.
    Am J Med Genet B Neuropsychiatr Genet; 2004 Apr 01; 126B(1):116-21. PubMed ID: 15048660
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hoarding in obsessive-compulsive disorder and related disorders: a preliminary report of 15 cases.
    Seedat S, Stein DJ.
    Psychiatry Clin Neurosci; 2002 Feb 01; 56(1):17-23. PubMed ID: 11929567
    [Abstract] [Full Text] [Related]

  • 6. Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders.
    Arnold PD, Siegel-Bartelt J, Cytrynbaum C, Teshima I, Schachar R.
    Am J Med Genet; 2001 May 08; 105(4):354-62. PubMed ID: 11378850
    [Abstract] [Full Text] [Related]

  • 7. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.
    J Clin Psychopharmacol; 2002 Apr 08; 22(2):148-54. PubMed ID: 11910259
    [Abstract] [Full Text] [Related]

  • 8. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients.
    Ford LC, Sulprizio SL, Rasgon BM.
    Laryngoscope; 2000 Mar 08; 110(3 Pt 1):362-7. PubMed ID: 10718420
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L.
    Am J Psychiatry; 1999 Sep 08; 156(9):1409-16. PubMed ID: 10484953
    [Abstract] [Full Text] [Related]

  • 13. Hoarding in obsessive-compulsive disorder: a report of 20 cases.
    Winsberg ME, Cassic KS, Koran LM.
    J Clin Psychiatry; 1999 Sep 08; 60(9):591-7. PubMed ID: 10520977
    [Abstract] [Full Text] [Related]

  • 14. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
    Gothelf D, Michaelovsky E, Frisch A, Zohar AH, Presburger G, Burg M, Aviram-Goldring A, Frydman M, Yeshaya J, Shohat M, Korostishevsky M, Apter A, Weizman A.
    Int J Neuropsychopharmacol; 2007 Jun 08; 10(3):301-8. PubMed ID: 16734939
    [Abstract] [Full Text] [Related]

  • 15. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
    Bejerot S, Edman G, Anckarsäter H, Berglund G, Gillberg C, Hofvander B, Humble MB, Mörtberg E, Råstam M, Ståhlberg O, Frisén L.
    Nord J Psychiatry; 2014 Nov 08; 68(8):549-59. PubMed ID: 24568661
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J, Hakimshooshtary M.
    Eur Child Adolesc Psychiatry; 2009 Mar 08; 18(3):131-5. PubMed ID: 19190958
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preschool children with obsessive-compulsive disorder and fluoxetine treatment.
    Ercan ES, Kandulu R, Akyol Ardic U.
    Eur Child Adolesc Psychiatry; 2012 Mar 08; 21(3):169-72. PubMed ID: 22271063
    [Abstract] [Full Text] [Related]

  • 20. Can early improvement be an indicator of treatment response in obsessive-compulsive disorder? Implications for early-treatment decision-making.
    da Conceição Costa DL, Shavitt RG, Castro Cesar RC, Joaquim MA, Borcato S, Valério C, Miguel EC, Diniz JB.
    J Psychiatr Res; 2013 Nov 08; 47(11):1700-7. PubMed ID: 23948637
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.